Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
2-year Genotropin treatment in short prepubertal children with intra-uterine growth retardation
2014-004160-38Phase 3
- Sponsor
- Kabi Pharmacia
- Start
- Apr 2015
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 3, randomised trial of somatropin in Growth disorder (3 arms), sponsored by Kabi Pharmacia. Primary endpoint: Change From Baseline in Annual Growth Rate at 2 Years.
02
Drugs
somatropin
03
Conditions
Growth disorder
Beyond the preview
Go deeper on 2014-004160-38.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2014-004160-38.